Concepedia

Nikole Varhegyi

NV

Statistics

Publications

18

Citations

735

H-Index

16

Active since

2013

Affiliations

University of Virginia(Current)

Washington University in St. Louis

Emory University

Johns Hopkins University

University of Virginia Cancer Center

Nikole Varhegyi is an author at University of Virginia specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2013–2024

18

Publications

18

A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patients

Marit M. Melssen, Gina R. Petroni, Kimberly A. Chianese‐Bullock et al. · Journal for ImmunoTherapy of Cancer · 2019 · 99 citations · Full text

Medicine, Immunology, Oncology +17

A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma

Patrick M. Dillon, Gina R. Petroni, Bethany J. Horton et al. · Clinical Cancer Research · 2017 · 85 citations · Full text

Medicine, Oncology, Pharmacology +16

MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma

Víctor H. Engelhard, Rebecca C. Obeng, Kara L. Cummings et al. · Journal for ImmunoTherapy of Cancer · 2020 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Results of an early safety analysis of a study of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer

Linda Duska, Jennifer Scalici, Sarah M. Temkin et al. · Cancer · 2020 · 68 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund’s adjuvant (IFA) for resected high-risk melanoma

Sapna P. Patel, Gina R. Petroni, Jason Roszik et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 18